Home/Filings/8-K/0001193125-26-014695
8-K//Current report

BCB BANCORP INC 8-K

Accession 0001193125-26-014695

$BCBPCIK 0001228454operating

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 8:45 AM ET

Size

144.0 KB

Accession

0001193125-26-014695

Research Summary

AI-generated summary of this filing

Updated

BCB Bancorp Reports $15.1M Impairment on Cannabis-Related REO

What Happened

  • On January 13, 2026, BCB Bancorp announced the board and management determined a $15.1 million pre-tax write-down was required for an isolated cannabis-related real estate owned (REO) property. This builds on a prior charge-off and reserve activity: the related loan was moved to REO in Q3 2025, with a previously disclosed $12.7 million charge-off and elimination of an established reserve.
  • The company also said its fourth quarter 2025 results will include $16.4 million in additional net charge-offs, mainly from the Bank’s commercial & industrial (C&I) loan portfolio. The largest single charge-off was $6.4 million; about $1.4 million of the net charge-offs related to the Bank’s “Business Express” loans. BCB Bancorp plans to release full Q4 2025 financial results on January 30, 2026 at 8:30 a.m. EST.

Key Details

  • $15.1 million pre-tax write-down on an isolated cannabis-related REO property (determined Jan 13, 2026).
  • $16.4 million additional net charge-offs to be recorded in Q4 2025; largest was a $6.4M C&I loan; ~$1.4M from Business Express loans.
  • Prior related actions: loan transferred to REO in Q3 2025 with a $12.7M charge-off and reserve elimination.
  • Company states the Bank has sufficient capital to absorb these losses and estimates no future cash outlays will result (subject to ongoing review).

Why It Matters

  • These items will reduce reported Q4 2025 earnings and book value for BCB Bancorp due to the impairment and additional charge-offs. For investors, the filing highlights credit losses concentrated in a cannabis-related REO and C&I lending, but the company says capital is adequate and does not expect material operational impact. The scheduled Q4 financial release (Jan 30, 2026) should provide full details and any further balance-sheet or capital effects.